Johnson & Johnson (JNJ)
155.47
+2.36
(+1.54%)
USD |
NYSE |
Nov 21, 13:44
Johnson & Johnson Price to Book Value: 5.335 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 5.254 |
| November 19, 2024 | 5.250 |
| November 18, 2024 | 5.311 |
| November 15, 2024 | 5.285 |
| November 14, 2024 | 5.212 |
| November 13, 2024 | 5.259 |
| November 12, 2024 | 5.238 |
| November 11, 2024 | 5.320 |
| November 08, 2024 | 5.335 |
| November 07, 2024 | 5.378 |
| November 06, 2024 | 5.418 |
| November 05, 2024 | 5.434 |
| November 04, 2024 | 5.430 |
| November 01, 2024 | 5.495 |
| October 31, 2024 | 5.486 |
| October 30, 2024 | 5.512 |
| October 29, 2024 | 5.494 |
| October 28, 2024 | 5.546 |
| October 25, 2024 | 5.521 |
| October 24, 2024 | 5.617 |
| October 23, 2024 | 5.692 |
| October 22, 2024 | 5.609 |
| October 21, 2024 | 5.588 |
| October 18, 2024 | 5.666 |
| October 17, 2024 | 5.644 |
| Date | Value |
|---|---|
| October 16, 2024 | 5.638 |
| October 15, 2024 | 5.631 |
| October 14, 2024 | 5.545 |
| October 11, 2024 | 5.540 |
| October 10, 2024 | 5.508 |
| October 09, 2024 | 5.512 |
| October 08, 2024 | 5.479 |
| October 07, 2024 | 5.474 |
| October 04, 2024 | 5.50 |
| October 03, 2024 | 5.507 |
| October 02, 2024 | 5.530 |
| October 01, 2024 | 5.558 |
| September 30, 2024 | 5.561 |
| September 27, 2024 | 5.431 |
| September 26, 2024 | 5.431 |
| September 25, 2024 | 5.404 |
| September 24, 2024 | 5.478 |
| September 23, 2024 | 5.492 |
| September 20, 2024 | 5.524 |
| September 19, 2024 | 5.546 |
| September 18, 2024 | 5.591 |
| September 17, 2024 | 5.622 |
| September 16, 2024 | 5.619 |
| September 13, 2024 | 5.570 |
| September 12, 2024 | 5.540 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.895
Minimum
Jul 08 2024
7.092
Maximum
Jan 26 2021
5.944
Average
6.010
Median
Nov 04 2022
Price to Book Value Benchmarks
| Amgen Inc | 20.68 |
| Eli Lilly and Co | 49.94 |
| Merck & Co Inc | 5.645 |
| Pfizer Inc | 1.538 |
| AbbVie Inc | 50.41 |
Price to Book Value Related Metrics
| PE Ratio | 25.70 |
| PS Ratio | 4.304 |
| Price to Free Cash Flow | 19.84 |
| Price | 155.47 |
| Earnings Yield | 3.89% |
| Market Cap | 374.31B |
| Operating PE Ratio | 16.54 |
| Normalized PE Ratio | 18.23 |